Clinical Outcomes of Chronic Kidney Disease Patients with STEMI Treated with Percutaneous Coronary Intervention: A Single Centre Study
Abstract: Background: Patients with advanced chronic kidney disease sustain extremely high mortality rates following acute myocardial infarction. Nauta et al. evaluated temporal trends in 12,087 patients with acute myocardial infarction from a single institution over 24 years and report a reduction in 30-day mortality in the most recent decade for all patients, including patients with chronic kidney disease. This trend is optimistic, but understanding contributory factors would be critical in future studies to further improve survival. Patients with renal impairment were often left out from most major clinical trials assessing the optimal treatment for ST-elevation myocardial infarction (STEMI). We aim to analyze the outcomes of STEMI patients with renal impairment treated with coronary angioplasty. Methods: STEMI patients treated with percutaneous coronary intervention (PCI) were stratified into presence (GFR
Keywords: Acute coronary syndrome,Chronic kidney disease, Drug-eluting stent, End-stage renal diseasePercutaneous Coronary Intervention
How to Cite?: Krishnakumar Prabhakaran, Mathew Iype, Prabha Nini Gupta, Sunitha Viswanathan, "Clinical Outcomes of Chronic Kidney Disease Patients with STEMI Treated with Percutaneous Coronary Intervention: A Single Centre Study", Volume 10 Issue 5, May 2021, International Journal of Science and Research (IJSR), Pages: 1004-1009, https://www.ijsr.net/getabstract.php?paperid=SR21519104059, DOI: https://dx.doi.org/10.21275/SR21519104059